NRXP NRX Pharmaceuticals Inc

$NRXP The shorts were betting on dilution. They were caught off guard by the DARPA funding. There is a 27% short float, 17 days to cover, and a 90% chance of FDA approval before November 10th. That could work out well.

$NRXP There is no better example of how a government bureaucracy messes everything up, than how the FDA is handling Ketafree. All they have to do look at a signature on a piece of paper. "Sorry guys, thats gonna take us until November 20 to do that. It's our rules". Lol. Sure it can happen before that date, and likely will. Those should have and could have easily of been handled within a week. But thats the government for you.

$NRXP In the CANTOR investor event NRXP/Javitt gave (11 Sept), at around the 19 to the 23 minute mark, he gave a good explanation of whats going on with the FDA and the vial they want to use. Also mentioned he thinks its a non-issue and something about a potential Oct approval. Again, go to NRXPs website, INVESTORS, EVENTS and find the one associated with the CANTOR investor conference.. Enjoy

$NRXP Dr. Javitt said mid-October in the Cantor talk; the new GDUFA date is November 10. We'll see whether the FDA actually takes all that time.

$NRXP Just opened a position! 🚀 FDA decision approaching on Nov 10. Bullish on the potential! 🔥

$NRXP …. as someone who has had both repetitive TMS & IV ketamine therapy, I can tell you this is a significant development. Being able to precisely target the area of the brain in need of repair and to also be able to quantify outcomes is incredible! AND, to be able to accomplish this with less visits…even better!

$NRXP NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

$NRXP Wait, what is going on here? We get good news (European patent rights for GNK-301) and we actually go up??

$NRXP this is getting silly. Unless they are completely lying about only have a minor issue to fix then they will get FDA approval within the next month or so.

$NRXP On August 11th, I commented on someone's post about NRXP. It would take about 3 months for NRXP's ANDA to get approved. Based on the new GDUFA goal date Nov 10, it seems what I said will highly likely become true.

$NRXP Huge news for $NRXP! FDA reclassified the major deficiency to a minor amendment with a new GDUFA goal date set for Nov 10, 2026. Selling early today was definitely a mistake.

$NRXP Lot of people questioning their investment here as the price languishes to FDA decision. Just some aprox. numbers. Ketamine market value for 2025 is about 4 billion projected to reach 7 billion plus by 2031. Now, the patent they secured for preservative free ketamine is good till 2045. So, if they get approval, which the fda is not flagging any issues besides the leur lock, why would you want to inject your patients with preservatives opening the door for adverse reactions which some patients have had. What if they are able to garner, lets say 10% of the market. That would be aprox.$400 million? Yeah, we don't have that approval yet but if NRXP gets that stamp, it should see some major repricing. Do they open up the ATM? To be expected, this is a small bio. I just don't think the raise will be at these share prices. Just some thoughts as we all wait. Cheers-

$NRXP The $11.18M DARPA contract is more important than the dollar amount alone. It provides non-dilutive funding for the FDA-cleared SPARC-TMS Phase 2/3 program and potentially expands NRX-101 from bipolar depression into the much larger treatment-resistant depression market. Combined with the upcoming KETAFREE decision, NRXP is becoming increasingly de-risked without having to finance every development step through dilution.

$NRXP today’s news is great for shareholders (potentially) 2-3 years down the road. What we need is news that helps shareholders that have been holding the bags for 5+ years: Ketafree/nrx-100.

$NRXP Adding a few more. Seems like everything these days are trading on algos. No news in my opinion is making people nervous that they will never get fda approval. Look at the reality. They only have a minor issue. Things will be better in the coming months.

$NRXP Which retards are selling at this price? ANDA approval is within 2 months now. I don't understand the weird actions of the people selling down here. 🚀

$NRXP FDA does an important job, but efficiency is not one of them. WebProFab, Medisca, NBGS...all offer a FDA compliant/registered leur lock syringe bottles. Nephron who is the manufacturer for NRXP received approval in Dec. 2020. Someone just wanted to show who's in control... Approval soon? I think so. Cheers-

$NRXP big week for long shareholders. Should have confirmation of 3 year realtime stability on NRX-100 and Ketafree.

$NRXP $BFRI $ARDX These are the 3 stocks you need to hold for the next 12 months IMO. My favorite top 3 best bio return ideas. Current prices as of this post so you can track. $3.45, $1.25, $3.42. Unless the world goes to H then NRXP is all you need to hold because we'll all need NRX-100. 😁 If you read this and have some company I'm missing please share with me. Thanks.

$NRXP i topped up a few today, getting closer. Come on JJ been here since BRPA time to get some cash back. whats it been 6 years!!!